{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0090303",
      "entity_text" : "injury",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P80511",
      "entity_text" : "CGRP",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The administration of a CGRP 8-37, a CGRP antagonist, has been reported to reduce peripheral nerve injury induced sensory hypersensitivity.",
  "reading_complete" : "2020-07-28T14:30:13Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T14:29:12Z",
  "trigger" : "reduce",
  "evidence" : [ "CGRP 8-37 , a CGRP antagonist, has been reported to reduce peripheral nerve injury" ],
  "pmc_id" : "4325278",
  "score" : 0
}